• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本人非糖尿病肥胖个体中β细胞质量的变化。

Change in β-cell mass in Japanese nondiabetic obese individuals.

机构信息

Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

出版信息

J Clin Endocrinol Metab. 2013 Sep;98(9):3724-30. doi: 10.1210/jc.2013-1373. Epub 2013 Jun 13.

DOI:10.1210/jc.2013-1373
PMID:23766518
Abstract

AIM

The aim of this study was to clarify the change in β-cell mass in Japanese obese individuals.

METHODS

We obtained the pancreas at autopsy from 39 lean and 33 obese Japanese nondiabetic individuals (aged 47 ± 13 vs 47 ± 12 y, P = .83, body mass index 20.4 ± 1.6 vs 28.5 ± 3.9 kg/m(2), P < .01). Pancreatic sections were stained for insulin, and β-cell area (%BCA) was measured as the fraction of the β-cell area to the total pancreas area. β-Cell mass was then calculated as the product of %BCA and estimated pancreas weight. β-Cell replication and apoptosis were assessed by double staining for insulin and Ki67 and insulin and single-stranded DNA, respectively. The frequencies of insulin-positive duct cells and scattered β-cells were assessed as the surrogate markers of β-cell neogenesis. The α-cell area (%ACA) was also measured, and the %ACA to %BCA ratio was determined.

RESULTS

There was no increase in β-cell mass in obese individuals compared with lean individuals (0.6 ± 0.4 vs 0.7 ± 0.4 g, P = .12). β-Cell replication, β-cell neogenesis, and β-cell apoptosis were not significantly increased in the presence of obesity. There was no significant difference in %ACA to %BCA ratio between obese and lean individuals (0.91 ± 1.09 vs 0.75 ± 0.51, P = .47).

CONCLUSION

There was no increase in β-cell mass and no detectable change in β-cell turnover in Japanese obese individuals.

摘要

目的

本研究旨在阐明日本肥胖个体中β细胞质量的变化。

方法

我们从 39 名瘦型和 33 名肥胖非糖尿病日本个体中获得尸检胰腺(年龄 47±13 岁比 47±12 岁,P=0.83,体重指数 20.4±1.6 比 28.5±3.9kg/m²,P<0.01)。胰腺切片用胰岛素染色,β细胞面积(%BCA)作为β细胞面积占胰腺总面积的分数进行测量。然后将β细胞质量计算为%BCA 与估计胰腺重量的乘积。通过胰岛素和 Ki67 以及胰岛素和单链 DNA 的双重染色分别评估β细胞复制和凋亡。通过胰岛素阳性导管细胞和散在β细胞的频率评估β细胞新生的替代标志物。还测量了α细胞面积(%ACA),并确定了%ACA 与%BCA 的比值。

结果

与瘦型个体相比,肥胖个体的β细胞质量没有增加(0.6±0.4 比 0.7±0.4g,P=0.12)。肥胖存在时β细胞复制、β细胞新生和β细胞凋亡没有显著增加。肥胖和瘦型个体之间%ACA 与%BCA 的比值没有显著差异(0.91±1.09 比 0.75±0.51,P=0.47)。

结论

日本肥胖个体中β细胞质量没有增加,β细胞周转没有可检测到的变化。

相似文献

1
Change in β-cell mass in Japanese nondiabetic obese individuals.日本人非糖尿病肥胖个体中β细胞质量的变化。
J Clin Endocrinol Metab. 2013 Sep;98(9):3724-30. doi: 10.1210/jc.2013-1373. Epub 2013 Jun 13.
2
Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas.肥胖和糖尿病对手术切除的人胰腺中α细胞和β细胞质量的影响。
J Clin Endocrinol Metab. 2016 Jul;101(7):2874-82. doi: 10.1210/jc.2016-1374. Epub 2016 Apr 12.
3
Effects of Glucocorticoid Treatment on β- and α-Cell Mass in Japanese Adults With and Without Diabetes.糖皮质激素治疗对有和无糖尿病的日本成年人β和α细胞质量的影响。
Diabetes. 2015 Aug;64(8):2915-27. doi: 10.2337/db15-0151. Epub 2015 Apr 16.
4
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.2型糖尿病患者的β细胞缺陷及β细胞凋亡增加。
Diabetes. 2003 Jan;52(1):102-10. doi: 10.2337/diabetes.52.1.102.
5
Pancreas Fat and β Cell Mass in Humans With and Without Diabetes: An Analysis in the Japanese Population.日本人胰腺脂肪和β细胞质量与糖尿病:分析
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3251-3260. doi: 10.1210/jc.2017-00828.
6
β-cell mass and turnover in humans: effects of obesity and aging.人类胰岛β细胞质量和更新:肥胖和衰老的影响。
Diabetes Care. 2013 Jan;36(1):111-7. doi: 10.2337/dc12-0421. Epub 2012 Aug 8.
7
Pancreatic α-cell mass in obesity.肥胖症中的胰腺 α 细胞团。
Diabetes Obes Metab. 2017 Dec;19(12):1810-1813. doi: 10.1111/dom.12997. Epub 2017 Jul 13.
8
Islet number rather than islet size is a major determinant of β- and α-cell mass in humans.胰岛数量而非胰岛大小是人类β细胞和α细胞质量的主要决定因素。
J Clin Endocrinol Metab. 2014 May;99(5):1733-40. doi: 10.1210/jc.2013-3731. Epub 2014 Feb 11.
9
{beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes.人 2 型糖尿病中β细胞质量动态变化和胰岛细胞可塑性。
Endocrinology. 2010 Apr;151(4):1462-72. doi: 10.1210/en.2009-1277. Epub 2010 Feb 22.
10
Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults.出生体重和儿童时期肥胖史与日本成年人胰岛β细胞质量的关系。
Diabetologia. 2020 Jun;63(6):1199-1210. doi: 10.1007/s00125-020-05127-2. Epub 2020 Apr 1.

引用本文的文献

1
Evolving Characteristics of Type 2 Diabetes Mellitus in East Asia.东亚2型糖尿病的演变特征
Endocrinol Metab (Seoul). 2025 Feb;40(1):57-63. doi: 10.3803/EnM.2024.2193. Epub 2025 Jan 15.
2
A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes-2nd Edition (English version).日本糖尿病学会(JDS)共识声明:2型糖尿病患者药物治疗的推荐算法 - 第2版(英文版)
Diabetol Int. 2024 Jul 11;15(3):327-345. doi: 10.1007/s13340-024-00723-8. eCollection 2024 Jul.
3
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version).
日本糖尿病学会共识声明:2 型糖尿病药物治疗建议算法-第 2 版(英文版)。
J Diabetes Investig. 2024 Sep;15(9):1326-1342. doi: 10.1111/jdi.14202. Epub 2024 Jul 11.
4
Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy.糖尿病发病机制及糖尿病周围神经病变的病理学评价。
Pathol Int. 2024 Aug;74(8):438-453. doi: 10.1111/pin.13458. Epub 2024 Jun 18.
5
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes.2 型糖尿病中抗糖尿病药物的应用对胰岛β细胞质量和功能的影响及治疗意义。
J Diabetes Investig. 2024 Jun;15(6):669-683. doi: 10.1111/jdi.14221. Epub 2024 Apr 27.
6
Longitudinal changes in pancreatic volume and pancreatic fat with weight gain in Japanese without diabetes: An analysis using health check-up data.日本非糖尿病患者体重增加时胰腺体积和胰腺脂肪的纵向变化:基于健康体检数据的分析
Metabol Open. 2023 Jun 12;19:100250. doi: 10.1016/j.metop.2023.100250. eCollection 2023 Sep.
7
Signaling pathways that regulate adaptive β-cell proliferation for the treatment of diabetes.调节适应性β细胞增殖的信号通路,用于治疗糖尿病。
J Diabetes Investig. 2023 Jun;14(6):735-740. doi: 10.1111/jdi.14002. Epub 2023 Mar 5.
8
A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.日本糖尿病学会(JDS)的共识声明:2型糖尿病患者药物治疗的建议算法。
Diabetol Int. 2022 Dec 23;14(1):1-14. doi: 10.1007/s13340-022-00605-x. eCollection 2023 Jan.
9
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes.日本糖尿病学会的共识声明:2型糖尿病患者药物治疗的建议算法。
J Diabetes Investig. 2023 Jan;14(1):151-164. doi: 10.1111/jdi.13960. Epub 2022 Dec 23.
10
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations.中国和印度人群 2 型糖尿病的病理生理学、表型和管理。
Nat Rev Endocrinol. 2022 Jul;18(7):413-432. doi: 10.1038/s41574-022-00669-4. Epub 2022 May 4.